1. Home
  2. PROF vs SCD Comparison

PROF vs SCD Comparison

Compare PROF & SCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • SCD
  • Stock Information
  • Founded
  • PROF N/A
  • SCD 2003
  • Country
  • PROF Canada
  • SCD United States
  • Employees
  • PROF N/A
  • SCD N/A
  • Industry
  • PROF Medical/Dental Instruments
  • SCD Trusts Except Educational Religious and Charitable
  • Sector
  • PROF Health Care
  • SCD Finance
  • Exchange
  • PROF Nasdaq
  • SCD Nasdaq
  • Market Cap
  • PROF 238.5M
  • SCD 259.3M
  • IPO Year
  • PROF N/A
  • SCD N/A
  • Fundamental
  • Price
  • PROF $7.64
  • SCD $17.36
  • Analyst Decision
  • PROF Strong Buy
  • SCD
  • Analyst Count
  • PROF 2
  • SCD 0
  • Target Price
  • PROF $11.40
  • SCD N/A
  • AVG Volume (30 Days)
  • PROF 75.7K
  • SCD 62.6K
  • Earning Date
  • PROF 10-31-2024
  • SCD 01-01-0001
  • Dividend Yield
  • PROF N/A
  • SCD 9.63%
  • EPS Growth
  • PROF N/A
  • SCD N/A
  • EPS
  • PROF N/A
  • SCD N/A
  • Revenue
  • PROF $7,880,000.00
  • SCD N/A
  • Revenue This Year
  • PROF $56.87
  • SCD N/A
  • Revenue Next Year
  • PROF $161.94
  • SCD N/A
  • P/E Ratio
  • PROF N/A
  • SCD N/A
  • Revenue Growth
  • PROF 16.67
  • SCD N/A
  • 52 Week Low
  • PROF $7.11
  • SCD $11.33
  • 52 Week High
  • PROF $11.69
  • SCD $15.87
  • Technical
  • Relative Strength Index (RSI)
  • PROF 41.39
  • SCD 54.79
  • Support Level
  • PROF $7.55
  • SCD $17.36
  • Resistance Level
  • PROF $8.48
  • SCD $17.91
  • Average True Range (ATR)
  • PROF 0.30
  • SCD 0.39
  • MACD
  • PROF 0.05
  • SCD -0.06
  • Stochastic Oscillator
  • PROF 26.07
  • SCD 32.75

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About SCD LMP Capital and Income Fund Inc.

Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships.

Share on Social Networks: